Arrhythmias Flashcards
QT prolongation and torsades
QT prolongation can lead to torsades, a lethal ventricular tachyarrhythmia which is most commonly associated w/ drugs and can result in sudden cardiac death
Two types of arrhythmias
- Supraventricular: originating above the AV node
* example: sinus tachycardia, atrial fibrillation, atrial flutter, focal atrial tachycardia and superventricular reentrant tachycardia - Ventricular: originating below the AV node
* example: PVCs, ventricular tachycardia and V fib
Things known to prolong the QT interval
- Pre-existing cardiac condition or history of arrhythmia
- Class IA and class III antiarrhythmics (amiodarone, disopyramide, dofetilide, Dronrdarone, ibutilide, procainamide, quinidine, sotalol, Flecainide)
- Antibiotics: quinolones, macrolides, Bactrim, amantadine, foscarnet
- Azole antifungal’s particularly voriconazole
- Chemo and protease inhibitors
- Antidepressants: try cyclic’s, SSRIs (particularly Celexa and Lexapro) and trazodone (SERTRALINE IS PREFERRED AND CARDIAC PATIENTS)
- Antiemetic agents including serotonin receptor antagonist
- Antipsychotics (chlorpromazine, haldol, ziprasidone, risperidone, clozapine, quetiapine
- Methadone, droperadol, ranolazine , chloroquine, quinine
Pharmacologic treatment options
- Prior to starting any antiarrhythmic be sure to always check the patient’s electrolytes and run a toxicology screen
- Terminate the arrhythmia and restore and maintain normal sinus rhythm: class I and III
- Slow the ventricular rate during a supraventricular arrhythmia: class II AND IV
Vaughan Williams classification of antiarrhythmics
Ia: quinidine, procainamide, disopyramide (QT RISK)
Ib: lidocaine, mexiletine, and phenytoin
Ic: flecainide, propafenone
II: beta blockers esmolol and propanolol
III: amiodarone, dofetilide, dronedarone, ibutilide, sotalol (QT risk)
IV: verapamil, diltiazem
Class I antiarrhythmics
MOA: sodium channel blockers
Sub classified based on the duration of time they bind the sodium channel Ia are intermediate, IB are fast and Ic are long
Cast trial lead to blackbox warning for elevated mortality in class Ic
Class Ia antiarrhthmics
MOA: decrease conduction velocity, increased refractory period, and decrease automaticity
DRUGS: quinidine, procainamide, disopyramide (Norpace)
Quinidine
Take with food or milk to dec GI upset
Blackbox warning: may increase mortality in the treatment of a fib or flutter; control AV conduction before initiating (typically with digoxin)
Contraindication: concurrent use of quinolones that prolong the QT interval; second or third degree heart block, thrombocytopenia, TPP
Side effects: major G.I., diarrhea, stomach cramping, QT prolongation, nausea/vomiting, anorexia, lightheadedness, tendinitis, headache, thrombocytopenia and may present a positive Coombs’ test
Note: avoid changes and sodium intake as it can change quinidine levels
Procainamide
Has active metabolite which is renally cleared
Blackbox warning: fatal blood dyscrasia, drug-induced lupus, increased mortality
Contraindication: second/third degree heart block, SLP, torsades
Side effects: hypertension, rash, lupus like syndrome, QT prolongation, agranulocytosis
Monitoring: ECG, electrolytes, blood pressure, renal function, signs of lupus, procainamide and NAPA levels
Disopyramide (Norpace)
Blackbox warning: class I affect of increased mortality due to CAST trial
Contraindications: second or third degree heart block, cardiogenic shock, congenital QT syndrome, sick sinus syndrome, BPH, narrow angle glaucoma, myasthenia gravis
Side effects: ANTI-CHOLINERGIC, hypotension, QT prolongation, heart failure exacerbation
Monitoring: ECG, electrolytes, blood pressure, signs of heart failure
Class Ib antiarrhythmics
Pure sodium channel blockers
Only useful for ventricular arrhythmias not useful for atrial fibrillation
They can all cross the blood brain barrier and therefore can call CNS adverse effects
Decrease conduction at higher heart rates, little effect on refractory period, & decrease automaticity
Drug: lidocaine, mexiletine
Lidocaine (Xylocaine)
IV, patch (on 12 off 12 due to risk of arrhythmia)
Contraindications: second or third degree heart block, Wolff-Parkinson-White syndrome, Adam Stokes syndrome, allergy to corn or corn related products
Side effects: lightheadedness, dizziness, incoordination, nausea/vomiting, tremor, CNS effects such as hallucinations, disorientation and confusion
Notes: caution in patients with severe hepatic dysfunction and elderly
Clas Ic Antiarrhythmics
Sodium channel blockers
ABSOLUTELY CONTRAINDICATED IN PATIENTS WITH HEART FAILURE OR WHO HAVE JUST EXPERIENCED AN ACUTE MYOCARDIAL INFARCTION
Drugs: Flecainide, propafenone (rythmol)
Flecainide
Blackbox warning: preemptive negative chronotropic therapy with digoxin or beta blocker they lower the risk of AV conduction problem; pro arrhythmic effect; cast trial showed increased harm
Contraindication: second or third degree heart block, cardiogenic shock, coronary artery disease such as heart failure or myocardial infarction and concurrent use of ritonavir or amprenavir
Side effects: dizziness, visual disturbances, headache, dyspnea, proarrhythmic
Propafenone (Rythmol)
Blackbox warning: cast trial showed inc harm
Contraindication: second or third degree heart block unless patient has pacemaker, sinus bradycardia, cardiogenic shock, hypertension, coronary artery disease such as heart failure or myocardial infarction, bronchospasm disorder or use of Ritonavir